Clinical study: coronary artery disease
Antibody against oxidized low density lipoprotein may predict progression or regression of atherosclerotic coronary artery disease

https://doi.org/10.1016/S0735-1097(01)01228-1Get rights and content
Under an Elsevier user license
open archive

Abstract

OBJECTIVES

This study aimed to elucidate whether an antibody against oxidized low density lipoprotein (anti-Ox-LDL) could predict short-term coronary artery atherosclerotic lesion progression.

BACKGROUND

It is still controversial whether higher levels of the anti-Ox-LDL titer are associated with atherosclerotic coronary artery disease.

METHODS

In 52 patients undergoing coronary angioplasty and six-month follow-up angiography, we performed quantitative coronary angiographic analysis of a lesion on a branch away from the intervention site vessel and assessed lesion progression or regression using the Progression-Regression score calculated as the baseline minimal lumen diameter minus the follow-up minimal lumen diameter. The serum anti-Ox-LDL titer was measured using an enzyme-linked immunosorbent assay method just before the initial angiography in all patients.

RESULTS

The anti-Ox-LDL titer was 16.6 ± 1.5 AcU/ml in the progression group (Progression-Regression score >0.15 mm; n = 20), which was significantly higher (p < 0.001) than the value of 9.5 ± 1.2 in the regression group (≤−0.15 mm; n = 14) and also higher (p < 0.01) than the value of 11.4 ± 1.3 in the no-change group (−0.15 to 0.15 mm; n = 18). The Progression-Regression score was correlated with the antibody titer in all patients (r = 0.56, p < 0.001). Multiple regression analysis showed that the Progression-Regression score was independently correlated with the antibody titer (r = 0.44, p < 0.01) as well as lipoprotein (a) (r = 0.33, p < 0.05).

CONCLUSIONS

Anti-Ox-LDL may be an independent predictor of coronary atherosclerotic lesion progression in the short term.

Abbreviations

AMI
acute myocardial infarction
ANOVA
analysis of variance
anti-Ox-LDL
antibody against oxidized low density lipoprotein
apo
apolipoprotein
ELISA
enzyme-linked immunosorbent assay
LDL
low density lipoprotein
Lp(a)
lipoprotein(a)
MDA
malonic dialdehyde
RLP
remnant-like lipoprotein particle

Cited by (0)

This study was supported in part by a grant from the Vehicle Racing Commemorative Foundation, Japan.